The most frequent AEs during sorafenib treatment were hand-foot syndrome, diarrhea and elevated aspartate aminotransferase, but the most frequent AEs during regorafenib treatment were elevated aspartate aminotransferase, elevated alanine aminotransferase and hand-foot syndrome. The gene discussed is GPT; the disease is Hand-foot syndrome.